Skip to main content
Top
Published in: Pituitary 2/2024

30-12-2023 | Acromegaly

Acromegaly increases depressive symptoms and reduces quality of life of cohabitants

Authors: Serhat Uysal, Cem Sulu, Zehra Kara, Ilker Ihtiyaroglu, Irem Ozkal, Serdar Sahin, Sabriye Sibel Taze, Mehmet Murat Kirpinar, Senol Turan, Pinar Kadioglu

Published in: Pituitary | Issue 2/2024

Login to get access

Abstract

Purpose

To assess how living with patients with acromegaly affects people’s psychology and quality of life (QoL).

Methods

Acromegaly patients and their cohabitants included in this study. Patients were administered Acromegaly Quality of Life Questionnaire (AcroQoL), Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI). Cohabitants were administered quality of life questionnaire (SF-36), BAI, BDI, and Zarit Caregiver Burden Interview (ZBI).

Results

This study included 84 patients with acromegaly and 84 cohabitants. Sixty-nine patients (n = 84, 82.1%) had an acromegalic appearance. Cohabitants who were affected by the acromegalic appearance had higher BAI, BDI, and ZBI scores than those who were not affected (p < 0.001 for all). Cohabitants who were affected by the acromegalic appearance had a significantly lower SF-36 score (p = 0.015). The BAI (r=-0.535, p < 0.001), BDI (r=-0.592, p < 0.001), and ZBI (r=-0.465, p < 0.001) scores of the cohabitants showed a negative correlation with AcroQoL. SF-36 scores showed correlation with AcroQoL (r = 0.387, p < 0.001).

Conclusion

The chronic process of acromegaly and the external appearance of patients with this disease can negatively affect both the patients and the people living with them. Physicians being aware of this effect and taking counteractive measures may contribute positively to the course of acromegaly.
Literature
5.
go back to reference Trotman-Dickenson B, Weetman AP, Hughes JM (1991) Upper airflow obstruction and pulmonary function in acromegaly: relationship to Disease activity. Q J Med 79:527–538PubMed Trotman-Dickenson B, Weetman AP, Hughes JM (1991) Upper airflow obstruction and pulmonary function in acromegaly: relationship to Disease activity. Q J Med 79:527–538PubMed
6.
16.
go back to reference Webb SM, Colao A, Caron P et al (2006) A European prospective real-life observational study of quality of life in patients with acromegaly. Endocr Abstr 11:OC20 Webb SM, Colao A, Caron P et al (2006) A European prospective real-life observational study of quality of life in patients with acromegaly. Endocr Abstr 11:OC20
18.
go back to reference Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A (1999) Kısa form-36 (KF36)’nın Türkçe versiyonunun güvenirliliği ve geçerliliği. İlaç ve Tedavi Derg 12:102–106 Koçyiğit H, Aydemir Ö, Ölmez N, Memiş A (1999) Kısa form-36 (KF36)’nın Türkçe versiyonunun güvenirliliği ve geçerliliği. İlaç ve Tedavi Derg 12:102–106
21.
go back to reference Ulusoy M, Şahin N, Erkmen H (1998) Turkish version of the Beck anxiety inventory: Psychometric Properties. J Cogn Psychother 12:163–171 Ulusoy M, Şahin N, Erkmen H (1998) Turkish version of the Beck anxiety inventory: Psychometric Properties. J Cogn Psychother 12:163–171
24.
go back to reference Hisli N (1989) Beck Depresyon Envanterinin üniversite öğrencileri için geçerliği, güvenirliği. Psikol Derg 7:3–13 Hisli N (1989) Beck Depresyon Envanterinin üniversite öğrencileri için geçerliği, güvenirliği. Psikol Derg 7:3–13
27.
go back to reference İnci F, Erdem M (2008) Bakım Verme Yükü Ölçeği’nin Türkçe’ye Uyarlanması Geçerlilik Ve Güvenilirliği. Atatürk Üniversitesi Hemşirelik Yüksekokulu Derg 11:85–95 İnci F, Erdem M (2008) Bakım Verme Yükü Ölçeği’nin Türkçe’ye Uyarlanması Geçerlilik Ve Güvenilirliği. Atatürk Üniversitesi Hemşirelik Yüksekokulu Derg 11:85–95
39.
go back to reference Yoshida K, Fukuoka H, Matsumoto R et al (2015) The quality of life in acromegalic patients with biochemical remission by Surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy. Using the Newly Developed Japanese Version of the AcroQoL Pituitary 18:876–883. https://doi.org/10.1007/s11102-015-0665-2CrossRefPubMed Yoshida K, Fukuoka H, Matsumoto R et al (2015) The quality of life in acromegalic patients with biochemical remission by Surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy. Using the Newly Developed Japanese Version of the AcroQoL Pituitary 18:876–883. https://​doi.​org/​10.​1007/​s11102-015-0665-2CrossRefPubMed
Metadata
Title
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants
Authors
Serhat Uysal
Cem Sulu
Zehra Kara
Ilker Ihtiyaroglu
Irem Ozkal
Serdar Sahin
Sabriye Sibel Taze
Mehmet Murat Kirpinar
Senol Turan
Pinar Kadioglu
Publication date
30-12-2023
Publisher
Springer US
Published in
Pituitary / Issue 2/2024
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-023-01376-7

Other articles of this Issue 2/2024

Pituitary 2/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.